MEI PHARMA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against MEI Pharma, Inc.Business Wire • 08/11/20
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 08/11/20
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against MEI Pharma, Inc. – MEIPBusiness Wire • 08/11/20
Pomerantz Law Firm Announces the Filing of a Class Action against MEI Pharma, Inc. and Certain Officers - MEIPPRNewsWire • 08/10/20
MEI Pharma Is Oversold Vs. The Value Of A Recent Executed Agreement And Peer Company ValuationSeeking Alpha • 07/29/20
MEIP Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of MEI Pharma, Inc. and Encourages Investors to Contact the FirmPRNewsWire • 07/06/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MEI Pharma, Inc. - MEIPPRNewsWire • 07/03/20
Is the Options Market Predicting a Spike in MEI Pharma (MEIP) Stock?Zacks Investment Research • 06/02/20
MEI Pharma and Kyowa Kirin Announces ME-401 Phase 1b Study to be Highlighted in a Presentation at the Virtual Edition of the 25th European Hematology Association Annual CongressPRNewsWire • 05/14/20
MEI Pharma, Inc. (MEIP) CEO Daniel Gold on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/29/19